arrow
G

Gurubasavaraja Swamy Purawarga Matada

acharya & bm reddy college of pharmacy
H指数:18
被引数:794

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Rational Design, Synthesis, Biological Evaluation, and In Silico Study of N-Cinnamamide/Benzamide-(4-(Substituted Phenyl)-6-(4-Cyclohexylphenyl)pyrimidin-2-Yl) Derivatives as EGFR Inhibitors Targeting EGFRWT, EGFRT790M, and EGFRL858R/T790M/C797S in NSCLC

理性设计、合成、生物评价及计算机模拟研究:<i>N</i>-肉桂酰胺/苯甲酰胺-(4-(取代苯基)-6-(4-环己基苯基)嘧啶-2-基)衍生物作为靶向NSCLC中EGFR<sup>WT</sup>、EGFR<sup>T790M</sup>和EGFR<sup>L858R</sup><sup>/T790M/C797S</sup>的EGFR抑制剂

2026-09-110
OA
Exploring tetrazole chemistry: synthetic techniques; structure–activity relationship; and pharmacological insights in antimicrobial and anticancer therapy

探索四唑化学:合成技术;构效关系;以及在抗菌和抗癌治疗中的药理学见解

2025-12-090
OA
In silico design, synthesis of a novel chalcone derivative and its in vitro and in vivo anticancer activity against colon cancer-induced mouse model

计算机辅助设计,一种新型查尔酮衍生物的合成及其在结肠癌诱导的小鼠模型中的体外和体内抗肿瘤活性

2025-09-100
PRE
Poly (ADP-ribose) polymerase (PARP) inhibitors as anticancer agents: An outlook on clinical progress, synthetic strategies, biological activity, and structure-activity relationship

作为抗癌药物的聚 (ADP-核糖) 聚合酶 (PARP) 抑制剂: 临床进展,合成策略,生物活性和构效关系的展望

2024-08-019
PRE